Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Fowler

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
JAMA|October 14, 2009
Critically ill patients with 2009 influenza A(H1N1) infection in CanadaAnand Kumar, Ryan Zarychanski, Ruxandra Pinto, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
Trials|February 1, 2018
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trialYaseen M Arabi, Adel Alothman, Hanan H Balkhy, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
Critical Care (London, England)|September 13, 2022
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Being ready to treat Ebola virus disease patientsDavid M Brett-Major, Shevin T Jacob, Frederique A Jacquerioz, et al.
Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
JAMA|October 14, 2009
Critically ill patients with 2009 influenza A(H1N1) infection in CanadaAnand Kumar, Ryan Zarychanski, Ruxandra Pinto, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
Trials|February 1, 2018
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trialYaseen M Arabi, Adel Alothman, Hanan H Balkhy, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
Critical Care (London, England)|September 13, 2022
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Being ready to treat Ebola virus disease patientsDavid M Brett-Major, Shevin T Jacob, Frederique A Jacquerioz, et al.
Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Pageof 24